Cargando…
Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
Autores principales: | Mayerhofer, Cristiane C.K., Awoyemi, Ayodeji, Hov, Johannes R., Trøseid, Marius, Broch, Kaspar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487724/ https://www.ncbi.nlm.nih.gov/pubmed/31034162 http://dx.doi.org/10.1002/ehf2.12437 |
Ejemplares similares
-
Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2018) -
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
por: Nendl, Andraž, et al.
Publicado: (2023) -
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
por: Trøseid, Marius, et al.
Publicado: (2020) -
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020) -
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
por: Awoyemi, Ayodeji, et al.
Publicado: (2021)